Last reviewed · How we verify
NCT03511417
The Effectiveness of Over the Counter Hearing Products for Middle-Aged Adults
NA trial testing over-the-counter hearing device in Hearing Loss, Functional. Withdrawn.
17 January 2020
Quick facts
| Lead sponsor | University of Massachusetts, Amherst |
|---|---|
| Phase | NA |
| Status | Withdrawn |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | treatment |
| Start date | 16 October 2018 |
| Primary completion | 17 January 2020 |
| Estimated completion | 17 January 2020 |
| Sites | 1 location across United States |
Drugs / interventions tested
- over-the-counter hearing device
Conditions studied
- Hearing Loss, Functional — all drugs for Hearing Loss, Functional →
Sponsor
University of Massachusetts, Amherst
Who can join
Adults 40 to 64, any sex, with Hearing Loss, Functional. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The investigators will examine the effectiveness of selected over-the-counter personal sound amplifiers in addressing functional hearing problems in middle-aged listeners with mild hearing loss. Many people are unlikely to pay several thousand dollars for hearing aids but they likely would be more willing to try a possible solution that is less expensive. When faced with counseling these individuals, audiologists are at a loss regarding whether or not to suggest that they try this type of technology, since there is virtually no research available to verify that these devices actually are helpful, particularly for individuals with mild hearing loss. The hypothesis being tested is that personal sound amplifiers can improve functional hearing and decrease cognitive load in complex auditory environments.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT03511417
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other University of Massachusetts, Amherst trials
Trials by the same sponsor.
- NCT07211373 — Advancing Student Suicide Interventions With Scalable Technologies · NA · enrolling by invitation
- NCT06990997 — Effects of Aphasia Identification Cards on Service Workers' Comprehension of People With Aphasia · NA · recruiting
- NCT07016555 — Burning Mouth Syndrome: Symptoms and Management · EARLY_PHASE1 · recruiting
- NCT06412016 — Urban Gardening and Peer Nutritional Counseling for People With HIV and Food Insecurity · NA · active not recruiting
- NCT06399939 — The Function of Biphasic Sleep in Infants · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03511417 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University of Massachusetts, Amherst
- Last refreshed: 20 October 2021
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03511417.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing